Discover
INKT
MiNK Therapeutics, Inc.
11.46
2 x 8.15
2 x 14.46
bid
ask
-
0.23
1.97%
2 @ 04:00 PM
11.48 +0.02 (0.18%)
| Ytd | 2.78% | |
| 1y | 56.13% |
11.16
day range
11.73
6.80
52 week range
76.00
| Open | 11.51 | Prev Close | 11.69 | Low | 11.16 | High | 11.73 | Mkt Cap | 57.09M |
| Vol | 12.20K | Avg Vol | 41.10K | EPS | -2.80 | P/E | N/A | Forward P/E | -1.17 |
| Beta | 0.05 | Short Ratio | 1.10 | Inst. Own | 2.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 11.53 | 200-d Avg | 12.07 | 1yr Est | 6.50 |
| Income Statement | |||
| Operating Expenses | 2.88M | ||
| Research and Development Expense | 1.20M | ||
| Selling, General and Administrative Expense | 1.68M | ||
| Operating Income | -2.88M | ||
| Net Income | -2.74M | ||
| Net Income Common Stock | -2.74M | ||
| Net Income Common Stock (USD) | -2.74M | ||
| Consolidated Income | -2.74M | ||
| Earnings per Basic Share | -0.57 | ||
| Earnings per Basic Share (USD) | -0.57 | ||
| Earnings per Diluted Share | -0.57 | ||
| Earning Before Interest & Taxes (EBIT) | -2.74M | ||
| Earning Before Interest & Taxes (USD) | -2.74M | ||
| Weighted Average Shares | 4.80M | ||
| Weighted Average Shares Diluted | 4.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.53M | ||
| Cash and Equivalents (USD) | 9.53M | ||
| Current Assets | 10.02M | ||
| Property, Plant & Equipment Net | 354.52K | ||
| Total Assets | 10.38M | ||
| Current Liabilities | 7.29M | ||
| Total Liabilities | 23.06M | ||
| Accumulated Retained Earnings (Deficit) | -159.42M | ||
| Accumulated Other Comprehensive Income | -697.43K | ||
| Shareholders Equity | -12.69M | ||
| Shareholders Equity (USD) | -12.69M | ||
| Assets Non-Current | 354.52K | ||
| Liabilities Non-Current | 15.78M | ||
| Trade and Non-Trade Payables | 19.17M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 36.07K | ||
| Net Cash Flow from Financing | -2.10M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.83M | ||
| Issuance (Purchase) of Equity Shares | 3.15M | ||
| Issuance (Repayment) of Debt Securities | -5.00M | ||
| Net Cash Flow from Operations | -1.73M | ||
| Effect of Exchange Rate Changes on Cash | -1.24K | ||
| Share Based Compensation | 630.39K | ||